glucosamine has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkner, K; Bittner, S; Löffel, J; Luchtman, D; Robohm, K; Stroh, A; Vogelaar, CF; Wasser, B; Zipp, F | 1 |
| Gran, B; Rostami, A; Yu, S; Zhang, GX | 1 |
2 other study(ies) available for glucosamine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
CNS-localized myeloid cells capture living invading T cells during neuroinflammation.
Topics: Animals; Cell Communication; Cell Death; Cell Survival; Central Nervous System; CX3C Chemokine Receptor 1; Encephalomyelitis, Autoimmune, Experimental; Glucosamine; Inflammation; Lectins, C-Type; Lymphocyte Activation; Mannose Receptor; Mannose-Binding Lectins; Mice; Myeloid Cells; Phagocytosis; Phosphatidylserines; Receptors, Cell Surface; Severity of Illness Index; T-Lymphocytes; Th17 Cells | 2020 |
Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response.
Topics: Administration, Oral; Animals; Antigen-Presenting Cells; Cell Proliferation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Glucosamine; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Lymphocytes; Mice; Multiple Sclerosis; Myelin-Associated Glycoprotein; Nitric Oxide; Spinal Cord; Th2 Cells; Time Factors | 2005 |